Revenue
2019
2020
2021
2022
2023
NP Life Sciences Health Industry Group Inc. (ACAT)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
Financial statements
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue | $164,621 | $102,002 | $34,992 | $15,000 | $43,000 |
| Operating income | −$690 | −$18,855 | −$65,681 | −$131,091 | −$108,859 |
| Net income | −$2,935 | −$18,856 | −$65,677 | −$131,065 | −$108,827 |
| Basic EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |